This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In a previous era, aspiring journalists relocated to New York, would-be actors made pilgrimages to Hollywood and plucky tech founders moved to the Bay Area so they could attract capital and talent. Use discount code TCPLUSROUNDUP to save 20% off a one- or two-year subscription. “We Code quality. Budding Biotech.
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. tied) Insider , $500M, digital marketing: Marketing tech platform Insider raised a $500 million Series E led by General Atlantic to fund its expansion in the U.S.
In fact, it took $200 million or more to make the list last month, as defense tech and cybersecurity led the way. Lambda , $480M, artificial intelligence: Lambda, which offers cloud computing services and hardware for training artificial intelligence software, raised a $480 million Series D co-led by Andra Capital and SGW.
Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. These tools can essentially “code” a molecule so that it reliably sticks to a specific substance or cell type, which allows a variety of follow-up actions to be taken.
Enterprise tech and AI Cerebras Systems : Yes, this one is kind of cheating. national security review on UAE-based G42 ‘s minority investment in the AI chipmaker. Gen Teare Health and biotech Hinge Health : This is another IPO prediction where were not exactly going out on a limb (pun intended in this case).
That increase was due in large part to U.S. The most valuable new 2024 unicorn company from China is Huawei Technologies smart car subsidiary Yinwang Smart Technology , valued at $16 billion. Healthcare and biotech was the third-highest sector for new unicorns with nine companies. leadership in AI.
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. The Norwalk, Connecticut-based firm did not disclose investor names, instead saying it came from a private investor whose portfolio focuses on global technology and real estate investments.
Now, certain industries are emerging as potential areas where New Zealand can win in the tech space. Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. New Zealanders make really good founders.
Now tech companies across industries are poised for an even better year, according to more than a dozen investors we talked to in the country. Other investors felt that a broader range of industries, like fintech and biotech, would eventually produce the biggest companies in the country. Zoomin Software.
Full TechCrunch+ articles are only available to members Use discount code TCPLUSROUNDUP to save 20% off a one- or two-year subscription Before Silicon Valley Bank crashed, I asked seven VCs about the startups they’re interested in backing right now, how they prefer to be approached and whether they could share any tips for first-time founders. “The
Nerdio , $500M, information technology: IT professionals are stretched pretty thin these days, so it makes sense that a company that helps automate some of their work could raise big. Latigo Biotherapeutics , $150M, biotech: Many patients shy away from taking opioids while many doctors are reluctant to prescribe the painkillers.
According to research, 85% of African SMBs have zero access to financing, and e ach day, African SMBs have billions locked up in receivables due to long payment cycles. ” All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits. Ghansah is a serial entrepreneur.
Not only does the software help sort and analyze ultrasound images to help doctors diagnose cardiovascular disease, but it also streamlines the workflow by generating patient reports for doctors that can then be added to a patient’s health record. Having more tech talent on board will help HeartLab advance its product offering.
He believes that the tech ecosystem has matured quite a lot in France over the past ten years. France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem.
Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.
It speaks to the speed with which genetics has permeated our lives, but despite massive improvements to the technology, the process can still be a bit clunky in the lab. Before you can even start to disentangle someone’s genetic code, you have to start with a sample. The fourth company is a biotech firm interested in synthetic biology.
“InstaDeep happened to be quite different from other companies in our pipeline as they were actually into deep tech versus applying technology to a certain sector, where basically, you become an operator in that sector. And it was also interesting, especially in Africa, where such companies are quite rare.
Every branch of science is increasingly reliant on big data sets and analysis, which means a growing confusion of formats and platforms — more than inconvenient, this can hinder the process of peer review and replication of research. That, at least, is the pitch Code Ocean offers for its platform and “Compute Capsules.”
These near-invisible bits of code are typically embedded in web pages to share information about users’ activity, often for analytics. Cerebral said these trackers inadvertently collected sensitive user data since it began operating in October 2019. In its disclosure to the U.S.
Once samples are scanned in the lab, they could be reviewed by hematologists working from anywhere. For instance, some papers argue, the manual review of samples doesn’t often add much to doctors’ diagnostic dataset. Think of this like support software that helps a hematologist distinguish between cell types.).
Research on psychedelics was stalled for decades due to DEA scheduling, but capabilities in the fields of pharmacology and medicinal chemistry advanced significantly during this “dark age.” Most ancillary services and technology will not take off until drugs commercialize, so we see few near-term opportunities in other verticals anyway.
He puts his tally for the number of applications he’s reviewed in the “tens of thousands.” What I’m looking for is technical excellence on the team,” Caldwell said. If anyone can answer that, it’s Dalton Caldwell, managing director and group partner for YC. They tend to get ripped off.
In 2020, Scottish startups collectively raised £345 million, according to Tech Nation, and with nearly 2,500 startups, it has the highest number of budding tech companies outside London. Use discount code SCOTLANDSURVEY to save 25% off an annual or two-year Extra Crunch membership. Which sectors is your tech ecosystem strong in?
There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software.
For perspective, we charted investment totals, color-coded by stage, for the past 11 quarters below. While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector. billion went to late-stage and technology growth deals in Q3 of 2024. A total of $23.8
Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. It also included a $50 million investment from advertising software firm AppLovin. This week, Obsidian Therapeutics leads the way.
Meatable has a long road ahead of it, because, as Gates acknowledged in his interview with MIT TechnologyReview (ed. These products don’t get at the full potential for cellular technology according to Daan Luining, Meatable’s chief technology officer. ” For Meatable right now, price remains an issue.
Despite advances in software to help model these compounds and molecules, there are still challenges in fully understanding their shapes through a two-dimensional computer screen. San Diego-based startup Nanome uses virtual reality to solve that problem. Nanome helps scientists get on the same page quicker,” he wrote in an email.
OK, with that, here’s what I think will happen next year: the return to in-person, five-day work weeks for tech workers. Then, this year, the Great Resignation became the Great Reset, as employers fired large percentages of their staff due to changing macroeconomic conditions. The impact of hype with Clubhouse’s Paul Davison.
The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. To that end Automata has been investing in the software to manage and administer its labware and robots.
Healthvana , a health tech startup that began with a specific focus on providing patient information digitally for individuals living with HIV, is helping Los Angeles County roll out mobile vaccination records for COVID-19 using Apple’s Wallet technology. “We look and feel like Instagram.
Those with disclosed investments include a number bringing AI-enabled tools to sectors like legal tech, recruiting, code development and medical recordkeeping. San Francisco is experiencing a resurgence due to AI , which is borne out by Crunchbase data. This allows for front loading duediligence.
Serial Kenyan tech entrepreneur Mike Macharia has spent the last two decades helping enterprises like East Africa’s biggest telco Safaricom to create infrastructure that bolsters their growth. But I had never thought of building tech for us (the masses). CarePoint raises $10M to spread healthcare tech across Africa.
While Amsterdam garners the lion’s share of attention in the Netherlands tech ecosystem, the not-so-far-away region around Utrecht has its fair share of tech startups and investors, as is evidenced by our latest survey of locals, below. What industry sectors is your tech ecosystem strong in? Utrecht is a bit lagging.”
Automated driving company Wayve , data preparation company Scale AI and AI biotech company Xaira Therapeutics each raised billion-dollar rounds. Healthcare and biotech was the second-largest sector, raising $17 billion. Hardware companies — in large part due to AI infrastructure and semiconductor fundings — raised $11 billion.
In busier years for tech IPOs, the week after Labor Day is a brisk period for roadshows by companies looking to make an autumn market debut. None of the hot venture-backed tech companies seen as likely IPO prospects filed to go public in August. A number of biotechs also carried out IPOs.
Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Formation Bio , $372M, biotech: Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. billion, per Crunchbase.
For software companies acquired for a billion dollars or more, private equity acquired the majority this year to date. billion, and London-based Hg ’s $3 billion acquisition of legal and compliance tech startup AuditBoard , based in Cerritos, California. And had artificial intelligence startups Inflection AI , Character.ai
How to Disrupt Any Industry with Longevity Science: No PhD Required , with FOXO Technologies. Finding True Love in Tech Partnerships: The Dos and Don’ts , with Mambu. Tech Driven Biology and Chemistry: Solving Science’s Hardest Problems at Scale , with Amazon Web Services. Trust as the New Currency in Tech , with Egon Zehnder.
The firm didnt take part in a ton of big rounds either last month, although it did lead a $40 million seed round for Zarminali Health , a Chicago-based hybrid care startup that integrates specialists, tech and services to provide coordinated outpatient pediatric primary and specialty care. However, a16z was far from done with big-money deals.
Taken together, the data sets used to train algorithms are, in general, smaller than they should be, according to one meta-review of 152 studies published in the BMJ. Technology alone can’t solve all these issues; you can’t sort or provide data that isn’t there in the first place. A screenshot of Gesund’s validation platform.
Between his roles as co-leader of Mayfield Fund’s engineering biology practice and founder at IndieBio, Arvind Gupta reviewed approximately 470 startup pitches last year. There’s a lot of optimism that technology can still create real solutions that can drive real value creation. You asked me for some categories?
Koneksa has developed a software suite that works with a variety of devices, from portable spirometers to iPhones and Apple Watches. These devices capture data, from which software gleans clinically useful signals and organizes them for review by drug companies or healthcare providers running clinical trials. “The
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content